Drug Shortage Report for M-VENLAFAXINE XR
Report ID | 182171 |
Drug Identification Number | 02471302 |
Brand name | M-VENLAFAXINE XR |
Common or Proper name | M-Venlafaxine xr |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-01-16 |
Estimated end date | 2023-11-30 |
Actual end date | 2023-11-27 |
Shortage status | Resolved |
Updated date | 2023-12-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-12-04 | French | Compare |
v11 | 2023-12-04 | English | Compare |
v10 | 2023-10-05 | French | Compare |
v9 | 2023-10-05 | English | Compare |
v8 | 2023-07-28 | French | Compare |
v7 | 2023-07-28 | English | Compare |
v6 | 2023-05-02 | French | Compare |
v5 | 2023-05-02 | English | Compare |
v4 | 2023-02-20 | French | Compare |
v3 | 2023-02-20 | English | Compare |
v2 | 2023-01-20 | French | Compare |
v1 | 2023-01-20 | English | Compare |
Showing 1 to 12 of 12